Trazodone for Sleep Disruption After a Personal Injury Accident

James Wong — Founder & Pharmacist, LienScripts | December 15, 2025 | 7 min read

Trazodone is one of the most commonly prescribed medications for accident-related insomnia. Non-habit-forming, fast-acting, and safe alongside other injury medications, it treats the sleep disruption that follows nearly every significant personal injury — and that disruption is itself a compensable injury under California law.

[!KEY] Trazodone is the most commonly prescribed non-habit-forming sleep medication for post-injury insomnia — a SARI with no federal scheduling, no physical dependence risk, fast onset within the first week, and a safety profile that allows use alongside other PI medications for the entire duration of a case without creating the dependency concerns associated with benzodiazepines or Z-drugs.

Sleep Disruption After a Personal Injury Is Nearly Universal

If you have been in a serious accident, you are almost certainly not sleeping well. This is not a coincidence and it is not a personality trait — it is a predictable physiological and psychological consequence of trauma.

Injured patients lose sleep for multiple converging reasons: pain that intensifies at night without daytime distractions, physiological stress responses that keep the nervous system in a heightened alert state, anxiety and intrusive thoughts about the accident, and positional discomfort from injuries that limit normal sleeping positions. The result is a vicious cycle: poor sleep worsens pain perception, and worsened pain further disrupts sleep.

Trazodone is the medication treating physicians most commonly reach for when an injured patient presents with this pattern of post-injury insomnia.

What Is Trazodone?

Trazodone is classified as a serotonin antagonist and reuptake inhibitor (SARI). It was originally developed as an antidepressant — at high doses (300–600 mg/day), it functions as one. But at the much lower doses used for sleep (50–150 mg at bedtime), its primary clinical effect is powerful sedation, driven by its blockade of serotonin-2A receptors and histamine H1 receptors.

This dose-dependent pharmacology is clinically important. At sleep doses, trazodone shortens sleep onset time, reduces nighttime awakenings, and improves overall sleep architecture — without the dependency risks associated with benzodiazepines or Z-drugs.

Why Trazodone Is Preferred for Post-Injury Insomnia

Non-Habit-Forming

Trazodone is not a controlled substance. It carries no federal scheduling and creates no physical dependence with normal use. Patients can discontinue it when their sleep normalizes without a medically managed taper. This is a significant advantage over benzodiazepines (Ativan, Klonopin, Xanax) and Z-drugs (Ambien, Lunesta), which carry real dependency risks and are typically not appropriate for long-term use.

Fast Onset

Unlike some sleep medications that require weeks of consistent use before patients notice benefit, trazodone typically begins improving sleep within the first week. For injured patients who are sleep-deprived and in pain, this rapid onset matters clinically.

Safe Alongside Other PI Medications

Personal injury patients are rarely on a single medication. They typically take one or more analgesics, a muscle relaxant, possibly a neuropathic agent, and other supportive medications simultaneously. Trazodone has a well-characterized drug interaction profile and is generally safe in combination with the medications commonly prescribed in PI cases.

Does Not Suppress Respiratory Drive

Unlike opioids, trazodone does not suppress the respiratory drive during sleep. This matters when trazodone is used alongside opioid pain medications, which is common in serious injury cases.

Trazodone vs. Benzodiazepines and Z-Drugs

The alternative sleep medications frequently prescribed for insomnia — benzodiazepines like lorazepam and clonazepam, and Z-drugs like zolpidem (Ambien) — carry dependency risks that make them problematic for the extended treatment timelines of personal injury cases. Personal injury cases often take 12–36 months to resolve. A patient who starts a benzodiazepine or Z-drug at injury onset and uses it continuously until settlement may arrive at resolution with a new physiological dependency to manage.

Trazodone avoids this problem entirely. It can be used continuously for the duration of treatment without creating dependency.

Sleep Disruption as a Compensable Injury

[!NOTE] A trazodone prescription creates three distinct evidentiary benefits: it documents that the patient reported sleep disruption to a physician (not just an attorney), establishes that the physician found it clinically significant enough to warrant medication, and creates a dated timeline entry connecting the sleep disturbance to the injury treatment period.

In California personal injury law, sleep disruption following an accident is not dismissed as a minor complaint — it is recognized as a legitimate and compensable component of the patient's injury. This is consistent with the medical evidence: sleep deprivation has documented negative effects on pain processing, cognitive function, immune response, and psychological health.

The clinical significance extends to the case record. A treating physician who assesses a patient's sleep complaints and prescribes trazodone is creating a formal medical record that:

1. Documents that the patient reported sleep disruption to their physician (not just to their attorney)
2. Establishes that the physician evaluated the complaint and determined it was clinically significant enough to warrant pharmacological intervention
3. Creates a dated timeline entry in the medical record connecting the sleep disturbance to the injury treatment period

This is meaningful documentation. A patient who reports insomnia in their deposition but has no clinical record of ever discussing it with a doctor is in a weaker evidentiary position than one whose pharmacy and medical records show ongoing treatment for documented sleep disruption.

Worsened Pain and Slowed Healing from Poor Sleep

The medical consequences of sleep disruption in an injured patient go beyond fatigue. Research demonstrates that poor sleep:

• Lowers the pain threshold, causing injured patients to perceive the same amount of tissue damage as more painful
• Impairs the physiological repair processes that occur predominantly during deep sleep stages
• Slows cognitive recovery after traumatic brain injury
• Worsens mood, anxiety, and psychological resilience during an already difficult recovery

Treating sleep disruption with trazodone is thus not simply about comfort — it is an intervention that supports the patient's overall recovery trajectory.

[!KEY] Trazodone's non-controlled status means it can be prescribed continuously for the entire duration of a personal injury case — often 12 to 36 months — without the dependency and tapering concerns that would arise with benzodiazepines or Z-drugs, making it the clinically and legally appropriate choice for long-term post-injury insomnia.

Pharmacy Lien Coverage for Trazodone

Trazodone prescribed by a treating physician for injury-related insomnia is covered under a pharmacy lien with LienScripts. The documentation it creates in the pharmacy and medical records is clinically and legally important throughout the case.

Injured patients should not be managing post-injury insomnia without clinical support because they cannot afford a medication. Pharmacy lien coverage ensures continuity of care from the first prescription through final settlement.

[!KEY] Consistent trazodone refills throughout the case create a month-by-month timeline of documented sleep disruption — each refill is an independent data point showing that the physician continued to find the prescription clinically warranted, directly supporting a pain and suffering claim based on sleep deprivation.

To find out how pharmacy lien coverage works for your situation, visit for patients.

Related Resources

• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?